| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |